Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: AB Science, Aim, Alphageneron, Ambulero, Biogen, Biontech, Chipscreen, First Wave, Genmab, Janssen, Innocare, Moleculin, Pfizer, Plus, Sage.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Adocia, Advaccine, Asieris, Beigene, Brii, Curevac, Escugen, H. Lundbeck, Hoth, Inovio, Kintor, Merck, Nrx, Otsuka, Regeneron, Ridgeback, Roche, Sorrento, Tonghua Dongbao.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: SPR Therapeutics, Venus Concept.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamis, Avadel, Avidity, Boehringer, Enochian, Gilead, I-Mab, Leo, Omeros, Oyster Point, Regeneron, Revance, Roche, Saniona, Sanofi, Som, United, UCB, Xilio.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Histosonics, Thermo Fisher Scientific.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Apellis, BMS, Chiesi, Gilead, Janssen, Lava, Merck, Pfizer, Rhythm, Sobi.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cepheid.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Agilent, Electrocore, Feops, Varian.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adocia, Algernon, Asieris, Beigene, Blade, Cantargia, Eli Lilly, Homology, Kadimastem, Lundbeck, Merck, Otsuka, Pharmather, Regeneron, Revance, Roche, Sanofi, Sorrento, Viridian.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Corium, Curevac, Deciphera, Gensight, Hoth, Intelgenx, Nrx, Ocular, Protara, Sofie, Viiv.